Chiron Capital Management’s Vaxart VXRT Stock Holding History

Chiron Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4	Closed	–	–	437
2020 Q3	$0	Buy	+4	New	+$36	﹤0.01%	511

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Chiron Capital Management's VXRT Position: Q4 2020 in Review

Chiron Capital Management sold out of Vaxart (VXRT) in Q4 2020, closing a stake of 4 shares.

Chiron Capital Management first reported a position in VXRT in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 141 funds tracked by Wall St. Rank hold VXRT as of Q4 2020.

Chiron Capital Management reported no remaining Vaxart position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 4 Vaxart shares in Q4 2020.
Chiron Capital Management first reported a position in Vaxart in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Vaxart position peaked at $0 in Q3 2020.
141 funds tracked by Wall St. Rank held Vaxart as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.